Market cap
₹24 Cr
Market cap
₹24 Cr
Revenue (TTM)
₹314 Cr
P/E Ratio
--
P/B Ratio
1.3
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹0 Cr
ROE
-7.9 %
ROCE
-3.4 %
Industry P/E
234
EV/EBITDA
486.7
Debt to Equity
1.3
Book Value
₹1.4
EPS
₹-0
Face value
1
Shares outstanding
128,825,000
CFO
₹-13.53 Cr
EBITDA
₹1.17 Cr
Net Profit
₹0.40 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vivanta
| -5.0 | 6.7 | -1.0 | -34.5 | -21.1 | 17.8 | -- |
|
*
| -- | -- | -- | -- | -- | -- | -- |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Vivanta
| -46.7 | -25.4 | 191.2 | -48.8 | 256.8 | 189.6 | -17.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Services
| 8.4 | 17.2 | 29.1 | -- | -- | -- | -- |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vivanta
|
1.9 | 24.5 | 313.7 | -0.3 | -0.8 | -1.5 | -- | 1.3 |
| 92.7 | 256.7 | 84.3 | -15.4 | -41.8 | -3.4 | -- | 0.7 | |
| 26.9 | 55.5 | 37.6 | 13.1 | -- | 21.7 | 4.2 | 0.7 | |
| 352.0 | 350.2 | 0.8 | 0.3 | 39.0 | 0.9 | 1163.6 | 10.0 | |
| 470.0 | 26.9 | 0.1 | -2.1 | -5,300.0 | -15.2 | -- | 2.1 | |
| 83.7 | 151.7 | 99.1 | 3.8 | 8.9 | 2.9 | 40.1 | 1.0 | |
| 227.8 | 92.7 | 13.8 | 0.9 | -36.7 | 15 | 188.7 | 16.7 | |
| 123.0 | 124.4 | 35.7 | 2.0 | 5.0 | 9.8 | 61.8 | 6.6 | |
| 117.8 | 87.0 | 33.0 | 7.6 | -- | 24 | 11.5 | 2.5 | |
| 286.6 | 732.0 | 78.6 | 16.3 | -- | 6.2 | 54.7 | 1.5 |
No Review & Analysis are available.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
Incorporated
2013
Chairman
HA Parikh
Managing Director
HA Parikh
Headquarters
Ahmedabad, Gujarat
Website
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
The share price of Vivanta Industries Ltd is ₹1.90 (BSE) as of 22-Apr-2026 IST. Vivanta Industries Ltd has given a return of -21.07% in the last 3 years.
Since, TTM earnings of Vivanta Industries Ltd is negative, P/E ratio is not available.
The P/B ratio of Vivanta Industries Ltd is 1.35 times as on 22-Apr-2026, a 32 discount to its peers’ median range of 1.99 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
1.87
|
|
2024
|
48.51
|
2.68
|
|
2023
|
18.48
|
1.86
|
|
2022
|
11.02
|
1.13
|
|
2021
|
0.00
|
0.88
|
The 52-week high and low of Vivanta Industries Ltd are Rs 3.25 and Rs 1.45 as of 22-Apr-2026.
Vivanta Industries Ltd has a market capitalisation of ₹ 24 Cr as on 22-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Vivanta Industries Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.